The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutics Development Initiative, 2011Dopamine D1 Positive Modulators for the Treatment of Parkinson's Disease
Objective/Rationale:
L-DOPA is the standard treatment of Parkinson’s disease (PD) but prolonged use results in dyskinesia. D2 agonists often require L-DOPA supplementation and can cause side effects... -
Rapid Response Innovation Awards, 2011Alpha-synuclein and Tau Mislocalization to Dendritic Spines
Objective/Rationale:
In addition to motor disorders, Parkinson disease (PD) patients also suffer from cognitive deficits, which are believed to result from abnormal accumulation of alpha-synuclein, a... -
Resource: Utilizing DATATOP Biospecimens, 2011Identification and Validation of Blood-borne Autoantibody Biomarkers for Parkinson's Disease
Objective/Rationale:
We recently discovered that self-reactive antibodies (autoantibodies) are abundant in blood and that detection of certain types of autoantibodies reveals the presence of disease... -
LRRK2, 2011Impact of LRRK2 Kinase Activity on Synaptic Vesicle Trafficking
Objective/Rationale:
The presynaptic alteration seen in several LRRK2 disease model suggest that LRRK2 might influence synaptic function through effects on presynaptic proteins. The common G2019S... -
MJFF Research Grant, 2011Screening & Identification of Small-molecule Pharmacophores Modulating LRRK2 Activity
Objective/Rationale:
Excessive activity of a human enzyme, named “LRRK2”, is closely associated with Parkinson’s Disease (PD). Small chemical compounds that inhibit this enzyme may be extremely... -
MJFF Research Grant, 2011Analysis of a Viral Non-coding RNA as a Novel Therapeutic in a Chronic MPTP Pre-clinical Model of Parkinson's Disease and its Mechanism of Mitochondrial Protection
Promising Outcomes of Original Grant:
Previously, we identified a viral RNA which could act as a novel protective agent in models of PD, when delivered before experimental damage to neurons of the...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.